Literature DB >> 20207230

Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1.

Hideyuki Oguro1, Jin Yuan, Hitoshi Ichikawa, Tomokatsu Ikawa, Satoshi Yamazaki, Hiroshi Kawamoto, Hiromitsu Nakauchi, Atsushi Iwama.   

Abstract

Polycomb group (PcG) proteins are essential regulators of stem cells. PcG and trithorax group proteins mark developmental regulator gene promoters with bivalent domains consisting of overlapping repressive and activating histone modifications to keep them poised for activation in embryonic stem cells. Bmi1, a component of PcG complexes, maintains the self-renewal capacity of adult stem cells, but its role in multipotency remains obscure. Here we show that Bmi1 is critical for multipotency of hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs). B cell lineage developmental regulator genes, Ebf1 and Pax5, appeared to be transcriptionally repressed by bivalent domains before lineage commitment. Loss of Bmi1 resulted in a resolution of bivalent domains at the Ebf1 and Pax5 loci, leading to their premature expression in HSC/MPPs accompanied by accelerated lymphoid specification and a marked reduction in HSC/MPPs. Thus, Bmi1 is required to reinforce bivalent domains at key developmental regulator gene loci to maintain lineage specification poised for activation in adult stem cells. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207230     DOI: 10.1016/j.stem.2010.01.005

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  81 in total

1.  Control of B cell development by the histone H2A deubiquitinase MYSM1.

Authors:  Xiao-Xia Jiang; Quan Nguyen; YuChia Chou; Tao Wang; Vijayalakshmi Nandakumar; Peter Yates; Lindsey Jones; Lifeng Wang; Haejung Won; Hye-Ra Lee; Jae U Jung; Markus Müschen; Xue F Huang; Si-Yi Chen
Journal:  Immunity       Date:  2011-12-08       Impact factor: 31.745

Review 2.  Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.

Authors:  Martin Sauvageau; Guy Sauvageau
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

3.  BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma.

Authors:  J H Hsu; E R Lawlor
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

Review 4.  Epigenetics of haematopoietic cell development.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Immunol       Date:  2011-06-10       Impact factor: 53.106

Review 5.  Regenerating the epigenome.

Authors:  Maria J Barrero; Juan Carlos Izpisua Belmonte
Journal:  EMBO Rep       Date:  2011-02-11       Impact factor: 8.807

Review 6.  Concise review: hematopoietic stem cell aging and the prospects for rejuvenation.

Authors:  Martin Wahlestedt; Cornelis Jan Pronk; David Bryder
Journal:  Stem Cells Transl Med       Date:  2014-12-29       Impact factor: 6.940

Review 7.  Polycomb genes, miRNA, and their deregulation in B-cell malignancies.

Authors:  Gang Greg Wang; Kyle D Konze; Jianguo Tao
Journal:  Blood       Date:  2015-01-07       Impact factor: 22.113

8.  Contribution of Polycomb group proteins to olfactory basal stem cell self-renewal in a novel c-KIT+ culture model and in vivo.

Authors:  Bradley J Goldstein; Garrett M Goss; Rhea Choi; Dieter Saur; Barbara Seidler; Joshua M Hare; Nirupa Chaudhari
Journal:  Development       Date:  2016-10-27       Impact factor: 6.868

9.  Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome.

Authors:  N Hasegawa; M Oshima; G Sashida; H Matsui; S Koide; A Saraya; C Wang; T Muto; K Takane; A Kaneda; K Shimoda; C Nakaseko; K Yokote; A Iwama
Journal:  Leukemia       Date:  2016-10-03       Impact factor: 11.528

Review 10.  Deregulated Polycomb functions in myeloproliferative neoplasms.

Authors:  Goro Sashida; Motohiko Oshima; Atsushi Iwama
Journal:  Int J Hematol       Date:  2019-01-31       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.